Search results for "cost(s)"

showing 10 items of 332 documents

Cost-Utility Analysis Applied to the Treatment of Burn Patients in a Specialized Center

2007

Objective To discover the total costs and quality of life of burn patients in a specialist center classified by diagnosis-related groups (DRGs). Design Prospective study of 5-year follow-up from January 1, 1997, through December 31, 2001. Setting Burn Center of Valencia. Patients A total of 898 patients treated at the Burn Center of Valencia. Main Outcome Measures Hospital, extrahospital, caregiving, labor, and social costs of the burn patients grouped by DRG (code 457: extensive burns without operating room procedure; code 458: nonextensive burns with skin graft; code 459: nonextensive burns with wound debridement or other operating room procedure; code 460: nonextensive burns without oper…

AdultMalemedicine.medical_specialtyAdolescentTotal costBurn UnitsAllied Health PersonnelQuality of lifeOutcome Assessment Health CareHealth caremedicineHumansChildProspective cohort studyDiagnosis-Related Groupshealth care economics and organizationsAgedCost–utility analysisCost–benefit analysisbusiness.industryBurn centerHealth Care CostsLength of StayMiddle AgedSurgeryHospitalizationSpainCosts and Cost AnalysisQuality of LifeLife expectancyFemaleSurgeryBurnsbusinessArchives of Surgery
researchProduct

Type I Diabetes is the Main Cost Driver in Autoimmune Polyendocrinopathy

2019

Abstract Context Autoimmune polyendocrinopathy (AP), a chronic complex orphan disease, encompasses at least two autoimmune-induced endocrine diseases. Objective To estimate for the first time total, indirect and direct costs for patients with AP, as well as cost drivers. Design Cross-sectional cost of illness study. Setting Academic tertiary referral center for AP. Patients 146 consecutive, unselected AP patients. Intervention Interviews pertaining to patients’ socioeconomic situation covered a recall period of 12 months. Both the human capital (HCA) and the friction cost approaches (FCAs) were applied as estimation methods. Main outcome measures Direct and indirect annual costs, and sick l…

AdultMalemedicine.medical_specialtyCost estimateEndocrinology Diabetes and MetabolismClinical BiochemistryContext (language use)DiseaseBiochemistryYoung AdultIndirect costsEndocrinologyCost of IllnessInternal medicinemedicineHumansPolyendocrinopathies AutoimmuneAgedType 1 diabetesbusiness.industryBiochemistry (medical)Health Care CostsAutoimmune polyendocrinopathyMiddle AgedPrognosismedicine.diseaseCross-Sectional StudiesDiabetes Mellitus Type 1EndocrinologyCost driverSick leaveFemalebusinessFollow-Up StudiesThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Improved effectiveness from individualized dosing of self-administered biologics for the treatment of moderate-to-severe psoriasis: a 5-year retrospe…

2019

Background: Biologics for moderate-to-severe psoriasis are expensive and treatment substitutions may vastly increase cost. Moreover, administration regimens in routine practice may differ from recommended guidelines. Objectives: To evaluate long-term effectiveness, regimen, drug-survival, and efficiency of self-administered biologics in clinical practice. Methods: We performed a 5-year retrospective study in 72 patients (44 ± 14 years old) with moderate-to-severe psoriasis at the University Hospital La Plana (Vila-real, Spain), treated with subcutaneous biologics. We determined the effectiveness (PASI 75 or PASI < 5), and drug-survival using Kaplan-Meier estimates, and analyzed reasons for …

AdultMalemedicine.medical_specialtyIndividualized dosingCost effectivenessefficacySelf AdministrationKaplan-Meier EstimateDermatologyRoutine practiceDrug CostsustekinumabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineChart reviewPsoriasisUstekinumabmedicineHumansPsoriasisbiologicsIntensive care medicinecost-effectivenessRetrospective Studies030203 arthritis & rheumatologyBiological ProductsDrug Substitutionbusiness.industryModerate to severe psoriasisAdalimumabpsoriasisanti-TNFpersistenceMiddle Agedmedicine.diseaseUniversity hospitalSpainFemaleUstekinumabbusinessmedicine.drugJournal of Dermatological Treatment
researchProduct

Job absenteeism and arterial hypertension: results of a hypertension control program.

1992

This study reports the findings of one of the stages of a programme for the detection and control of arterial hypertension, started in I980 in an automobile company with a workforce of 9,782. In the initial screening, 522 hypertensive males were found using epidemiological criteria and 206 of these fulfilled the criteria of definite hypertension. The objective of this study consisted of evaluating, 9 years after the start of the program, the indirect cost in terms of the reduction in the morbidity indicator-temporary work incapacity (TWI). Analysis is based on a comparison of the prevalence of hypertension in the population when the program was begun (6%) and in 1989 (9.8%). It can be obser…

AdultMalemedicine.medical_specialtyPediatricsEpidemiologyPopulationBlood PressureIndirect costsClinical ProtocolsEpidemiologyAbsenteeismMedicineHumanseducationDiureticsOccupational HealthMonitoring Physiologiceducation.field_of_studybusiness.industryPublic healthIncidence (epidemiology)IncidenceHydralazinePropranololBlood pressureSpainWorkforceHypertensionAbsenteeismCosts and Cost AnalysisbusinessEuropean journal of epidemiology
researchProduct

Socio-economic cost and health-related quality of life of burn victims in Spain

2008

Abstract Objectives The aim of the study was to determine the economic burden (direct and indirect costs) of burn victims and the impact of burn on health-related quality of life in Spain. Methods In 2003, a cross-sectional study was carried out with 898 burned people. Data regarding demographic features, health resource use, informal care, indirect costs and quality of life were prospectively collected through hospital admission databases and questionnaires filled out by burn victims and caregivers. Results The mean annual cost (direct and indirect) per burn patient was US$ 99,773. The most important categories of costs were those of in-patient care and temporary and permanent disability. …

AdultMalemedicine.medical_specialtyPoison controlCritical Care and Intensive Care MedicineOccupational safety and healthIndirect costsQuality of life (healthcare)Cost of IllnessSurveys and QuestionnairesEnvironmental healthHealth caremedicineHumansProspective Studieshealth care economics and organizationsHealth policyCost–utility analysisbusiness.industryPublic healthHealth Care CostsGeneral MedicineSurgeryHospitalizationCross-Sectional StudiesCaregiversSocioeconomic FactorsSpainQuality of LifeEmergency MedicineFemaleSurgeryBurnsbusinessBurns
researchProduct

Knee arthroscopy and exercise versus exercise only for chronic patellofemoral pain syndrome: a randomized controlled trial.

2007

Abstract Background Arthroscopy is often used to treat patients with chronic patellofemoral pain syndrome (PFPS). As there is a lack of evidence, we conducted a randomized controlled trial to study the efficacy of arthroscopy in patients with chronic PFPS. Methods A total of 56 patients with chronic PFPS were randomized into two treatment groups: an arthroscopy group (N = 28), treated with knee arthroscopy and an 8-week home exercise program, and a control group (N = 28), treated with the 8-week home exercise program only. The arthroscopy included finding-specific surgical procedures according to current recommendations. The primary outcome was the Kujala score on patellofemoral pain and fu…

AdultMalemedicine.medical_specialtyRandomizationAdolescentKnee JointVisual analogue scalelcsh:Medicinelaw.inventionArthroscopyRandomized controlled triallawmedicineHumansPhysical Therapy ModalitiesMedicine(all)Knee arthroscopymedicine.diagnostic_testbusiness.industryArthroscopylcsh:RCase-control studyGeneral MedicineHealth Care Costsmedicine.diseaseConfidence intervalExercise TherapyTreatment OutcomePatellofemoral Pain SyndromeCase-Control StudiesPhysical therapyFemalebusinessDelivery of Health CarePatellofemoral pain syndromeFollow-Up StudiesResearch ArticleBMC medicine
researchProduct

Percutaneous liver biopsy: a safe outpatient procedure?

2001

Following the discovery of hepatitis C virus, more liver biopsies (LB) than before are being performed to assess the severity of liver disease. In this study, following the recommendations for outpatient LB made by the Patient Care Committee of the American Gastroenterological Association, we assessed the feasibility and benefits of LB performed as an outpatient versus inpatient procedure over the last 7 years in our centre. The study included 1,581 patients consecutively examined in our institute; all LBs were performed by a single operator with a 16-gauge needle using the Menghini technique, and in all cases the puncture site was determined using prebiopsy ultrasound. Liver lesions were c…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaCost ControlChronic liver diseaseLiver biopsy complicationLiver diseasePatient satisfactionAmbulatory careBiopsyAmbulatory CareMedicineHumansAgedRetrospective StudiesUltrasonographymedicine.diagnostic_testbusiness.industryPatient SelectionChronic liver diseaseBiopsy NeedleHaemobiliaGastroenterologyOutpatientRetrospective cohort studyHealth Care CostsMiddle Agedmedicine.diseaseSurgeryLiverPatient SatisfactionFemalebusinessComplicationDigestion
researchProduct

Robotic Versus Laparoscopic Gastric Resection for Primary Gastrointestinal Stromal Tumors5 cm: A Size-Matched and Location-Matched Comparison.

2017

This study compared robotic (RR) and laparoscopic resection (LR) for primary gastrointestinal stromal tumors (GISTs) of the stomach &gt;5 cm. Twelve consecutive patients who underwent RR from 2012 to 2015 were matched for tumor size and location with 24 patients who underwent LR from 2000 to 2012. The median tumor size was 7.1 cm (range, 5.5 to 11.5). GISTs were resected by wedge resection (91.7%) or distal gastrectomy. The median RR operative time was longer than that of LR (162.5 vs. 130 min, respectively; P=0.004). Only 1 LR patient required conversion. The time to flatus and hospital stay were similar between groups. Overall, 3 patients developed minor postoperative complications that w…

AdultMalemedicine.medical_specialtyStromal cellGastrointestinal Stromal TumorsOperative TimeBlood Loss Surgical030230 surgeryRobotic gastric resectionRisk Assessment03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRobotic Surgical ProceduresStomach Neoplasmslaparoscopic gastric resectionmedicineHumansLaparoscopic resectionGastric resectionUltrasonography InterventionalAgedAged 80 and overTumor sizebusiness.industryStomachIncidence (epidemiology)Length of StayMiddle AgedSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureTreatment OutcomeSurgery Computer-Assisted030220 oncology & carcinogenesisCosts and Cost AnalysisOperative timeSurgeryFemaleLaparoscopybusinessprimary gastrointestinal stromal tumorGISTWedge resection (lung)Surgical laparoscopy, endoscopypercutaneous techniques
researchProduct

The costs of social anxiety disorder: The role of symptom severity and comorbidities

2013

Abstract Background Social anxiety disorder (SAD) is associated with low direct costs compared to other anxiety disorders while indirect costs tend to be high. Mental comorbidities have been identified to increase costs, but the role of symptom severity is still vague. The objective of this study was to determine the costs of SAD, and to explore the impact of symptoms and comorbidities on direct and indirect costs. Methods Baseline data, collected within the SOPHO-NET multi-centre treatment study ( N =495), were used. Costs were calculated based on health care utilization and lost productivity. Symptom severity was measured with the Liebowitz-Social-Anxiety-Scale; comorbidities were include…

AdultMalemedicine.medical_specialtyTotal costPopulationComorbidityEfficiencySeverity of Illness IndexYoung Adult03 medical and health sciencesIndirect costs0302 clinical medicineCost of IllnessAbsenteeismmental disordersHealth caremedicineHumans030212 general & internal medicineSocial BehaviorPsychiatryeducationhealth care economics and organizationseducation.field_of_studybusiness.industrySocial anxietyMiddle Agedmedicine.diseaseAnxiety Disorders3. Good health030227 psychiatryPsychiatry and Mental healthClinical PsychologyEating disordersAbsenteeismAnxietyFemaleSelf Reportmedicine.symptomPsychologybusinessJournal of Affective Disorders
researchProduct

Excess costs of social anxiety disorder in Germany

2017

Abstract Background Social anxiety disorder is one of the most frequent mental disorders. It is often associated with mental comorbidities and causes a high economic burden. The aim of our analysis was to estimate the excess costs of patients with social anxiety disorder compared to persons without anxiety disorder in Germany. Methods Excess costs of social anxiety disorder were determined by comparing two data sets. Patient data came from the SOPHO-NET study A1 (n=495), whereas data of persons without anxiety disorder originated from a representative phone survey (n=3213) of the general German population. Missing data were handled by “Multiple Imputation by Chained Equations”. Both data se…

AdultMalemedicine.medical_specialtymedicine.medical_treatment03 medical and health sciencesIndirect costs0302 clinical medicinePrevalence of mental disordersCost of IllnessAmbulatory careGermanyAbsenteeismAmbulatory CaremedicineHumansPsychiatryhealth care economics and organizationsRehabilitationSocial anxietyPhobia SocialHealth Care CostsMiddle AgedDisability pensionmedicine.disease3. Good health030227 psychiatryPsychiatry and Mental healthClinical PsychologyAbsenteeismFemalePsychology030217 neurology & neurosurgeryAnxiety disorderJournal of Affective Disorders
researchProduct